Zach is a business development professional with over 25 years of experience in biotech, pharma and medtech industries. He currently serves as vice president and global head of corporate development & strategy for BioNTech SE where he helps drive strategic transactions and corporate strategy. Zach helped incubate his previous company, Neon Therapeutics, as a consultant to Third Rock Ventures, conducting diligence and helping create the company business plan culminating in a $55 million Series A financing in 2015. Zach was also a key contributor to Neon’s IPO process in 2018 and the eventual sale of the company to BioNTech in 2020. Prior to Neon, Zach held a number of business development roles and strategy roles at companies notably Millennium Pharmaceuticals (acquired by Takeda) and Philips Research in the Netherlands. While at Philips, Zach co-founded and helped spin out Tagworks Pharmaceuticals into an independent company.
Zach holds a BS in engineering physics from Cornell University and earned his MBA from the Kellogg School of Business– Northwestern University.